These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
564 related articles for article (PubMed ID: 23196781)
21. Outcomes of radical cystectomy for transitional cell carcinoma of the bladder: a contemporary series from the Bladder Cancer Research Consortium. Shariat SF; Karakiewicz PI; Palapattu GS; Lotan Y; Rogers CG; Amiel GE; Vazina A; Gupta A; Bastian PJ; Sagalowsky AI; Schoenberg MP; Lerner SP J Urol; 2006 Dec; 176(6 Pt 1):2414-22; discussion 2422. PubMed ID: 17085118 [TBL] [Abstract][Full Text] [Related]
22. Impact of adjuvant chemotherapy in patients with adverse features and variant histology at radical cystectomy for muscle-invasive carcinoma of the bladder: Does histologic subtype matter? Berg S; D'Andrea D; Vetterlein MW; Cole AP; Fletcher SA; Krimphove MJ; Marchese M; Lipsitz SR; Sonpavde G; Noldus J; Shariat SF; Kibel AS; Trinh QD; Mossanen M Cancer; 2019 May; 125(9):1449-1458. PubMed ID: 30620387 [TBL] [Abstract][Full Text] [Related]
23. A precystectomy decision model to predict pathological upstaging and oncological outcomes in clinical stage T2 bladder cancer. Mitra AP; Skinner EC; Miranda G; Daneshmand S BJU Int; 2013 Feb; 111(2):240-8. PubMed ID: 22928881 [TBL] [Abstract][Full Text] [Related]
24. The current and future application of adjuvant systemic chemotherapy in patients with bladder cancer following cystectomy. Aparicio AM; Elkhouiery AB; Quinn DI Urol Clin North Am; 2005 May; 32(2):217-30, vii. PubMed ID: 15862619 [TBL] [Abstract][Full Text] [Related]
25. Optimal Timing of Chemotherapy and Surgery in Patients with Muscle-Invasive Bladder Cancer and Upper Urinary Tract Urothelial Carcinoma. Tabayoyong W; Li R; Gao J; Kamat A Urol Clin North Am; 2018 May; 45(2):155-167. PubMed ID: 29650132 [TBL] [Abstract][Full Text] [Related]
26. Pathological response to neoadjuvant chemotherapy for muscle-invasive micropapillary bladder cancer. Meeks JJ; Taylor JM; Matsushita K; Herr HW; Donat SM; Bochner BH; Dalbagni G BJU Int; 2013 Jun; 111(8):E325-30. PubMed ID: 23384236 [TBL] [Abstract][Full Text] [Related]
27. [Is there an indication for adjuvant or neoadjuvant systemic chemotherapy in bladder cancer?]. Suttmann H; Retz M; Gschwend JE; Stöckle M Urologe A; 2007 Oct; 46(10):1379-80, 1382-4. PubMed ID: 17805506 [TBL] [Abstract][Full Text] [Related]
28. [Results of radical cystectomy for management of invasive bladder cancer with special reference to prognostic factors and quality of life depending on the type of urinary diversion]. Słojewski M Ann Acad Med Stetin; 2000; 46():217-29. PubMed ID: 11712306 [TBL] [Abstract][Full Text] [Related]
29. Timing cystectomy and perioperative chemotherapy in the treatment of muscle invasive bladder cancer. Izawa JI; Chin JL; Winquist E Can J Urol; 2006 Jun; 13 Suppl 3():48-53. PubMed ID: 16818012 [TBL] [Abstract][Full Text] [Related]
30. Systemic chemotherapy for muscle invasive bladder cancer. Ondrus D; Hornák M; Bárdos A; Ondrus B Neoplasma; 1994; 41(5):263-8. PubMed ID: 7854496 [TBL] [Abstract][Full Text] [Related]
31. The role of chemotherapy in the management of the patient with T3b bladder cancer. Millikan R; Dinney CP Semin Urol Oncol; 1996 May; 14(2):81-5. PubMed ID: 8734735 [TBL] [Abstract][Full Text] [Related]
32. Combining surgery and chemotherapy for invasive bladder cancer: current and future directions. Amiel GE; Lerner SP Expert Rev Anticancer Ther; 2006 Feb; 6(2):281-91. PubMed ID: 16445380 [TBL] [Abstract][Full Text] [Related]
33. Contemporary use of perioperative cisplatin-based chemotherapy in patients with muscle-invasive bladder cancer. Raj GV; Karavadia S; Schlomer B; Arriaga Y; Lotan Y; Sagalowsky A; Frenkel E Cancer; 2011 Jan; 117(2):276-82. PubMed ID: 20830767 [TBL] [Abstract][Full Text] [Related]
34. Current status of neoadjuvant and adjuvant chemotherapy for muscle-invasive bladder cancer. Rosenberg JE Expert Rev Anticancer Ther; 2007 Dec; 7(12):1729-36. PubMed ID: 18062747 [TBL] [Abstract][Full Text] [Related]
35. Radical cystectomy in the elderly: Comparison of survival between younger and older patients. Clark PE; Stein JP; Groshen SG; Cai J; Miranda G; Lieskovsky G; Skinner DG Cancer; 2005 Feb; 103(3):546-52. PubMed ID: 15630702 [TBL] [Abstract][Full Text] [Related]
36. Patterns of use of systemic chemotherapy for Medicare beneficiaries with urothelial bladder cancer. Porter MP; Kerrigan MC; Donato BM; Ramsey SD Urol Oncol; 2011; 29(3):252-8. PubMed ID: 19450992 [TBL] [Abstract][Full Text] [Related]
37. Importance of node dissection in relation to neoadjuvant and adjuvant therapy. Huang WC; Bochner BH J Natl Compr Canc Netw; 2006 Nov; 4(10):1019-26. PubMed ID: 17112450 [TBL] [Abstract][Full Text] [Related]
38. Angiotensin-II combined intra-arterial chemotherapy for locally advanced bladder cancer: a case series study at a single institution. Shimabukuro T; Nakamura K; Uchiyama K; Tei Y; Aoki A; Naito K Hinyokika Kiyo; 2006 Feb; 52(2):99-105. PubMed ID: 16541762 [TBL] [Abstract][Full Text] [Related]
39. Adjuvant and neoadjuvant chemotherapy for urothelial carcinoma. McCaffrey JA; Herr HW Surg Oncol Clin N Am; 1997 Oct; 6(4):667-81. PubMed ID: 9309087 [TBL] [Abstract][Full Text] [Related]
40. Pathologic response in patients receiving neoadjuvant chemotherapy for muscle-invasive bladder cancer: Is therapeutic effect owing to chemotherapy or TURBT? Brant A; Kates M; Chappidi MR; Patel HD; Sopko NA; Netto GJ; Baras AS; Hahn NM; Pierorazio PM; Bivalacqua TJ Urol Oncol; 2017 Jan; 35(1):34.e17-34.e25. PubMed ID: 27639777 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]